MPH Health Care AG
XETRA:93M1

Watchlist Manager
MPH Health Care AG Logo
MPH Health Care AG
XETRA:93M1
Watchlist
Price: 22.6 EUR -1.74% Market Closed
Market Cap: 96.8m EUR
Have any thoughts about
MPH Health Care AG?
Write Note

Net Margin
MPH Health Care AG

114 602.5%
Current
-9 974%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
114 602.5%
=
Net Income
29.5m
/
Revenue
25.8k

Net Margin Across Competitors

Country Company Market Cap Net
Margin
DE
MPH Health Care AG
XETRA:93M1
96.8m EUR
114 602%
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY
-79%
US
Eli Lilly and Co
NYSE:LLY
729.3B USD
20%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
DK
Novo Nordisk A/S
CSE:NOVO B
2.6T DKK
35%
US
Johnson & Johnson
NYSE:JNJ
347.8B USD
17%
US
Merck & Co Inc
NYSE:MRK
248.3B USD
19%
CH
Roche Holding AG
SIX:ROG
197.2B CHF
20%
UK
AstraZeneca PLC
LSE:AZN
159B GBP
13%
CH
Novartis AG
SIX:NOVN
169.7B CHF
35%
US
Pfizer Inc
NYSE:PFE
149.4B USD
7%
Country DE
Market Cap 96.8m EUR
Net Margin
114 602%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 729.3B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 2.6T DKK
Net Margin
35%
Country US
Market Cap 347.8B USD
Net Margin
17%
Country US
Market Cap 248.3B USD
Net Margin
19%
Country CH
Market Cap 197.2B CHF
Net Margin
20%
Country UK
Market Cap 159B GBP
Net Margin
13%
Country CH
Market Cap 169.7B CHF
Net Margin
35%
Country US
Market Cap 149.4B USD
Net Margin
7%
No Stocks Found

MPH Health Care AG
Glance View

Market Cap
96.8m EUR
Industry
Pharmaceuticals

MPH Health Care AG is an investment company, which engages in the acquisition and development of companies and shares in companies from the healthcare industry. The company is headquartered in Berlin, Berlin. The company went IPO on 2009-01-01. The firm focuses on the purchase, development and sale of companies and shares in companies from the healthcare market. The firm's portfolio comprises HAEMATO AG, M1 Kliniken AG and MPH Ventures. HAEMATO AG is a pharmaceutical company that offers generics for the therapies of cancer, human immunodeficiency virus (HIV) and other chronic diseases. M1 Kliniken AG focuses on the medicinal beauty market and develops and sells pharmaceutical and medical products and services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. MPH Ventures operates as venture capitalist and invests in Pharmigon GmbH, a company specialized in cytostatic admixture and concomitant medications, as well as in the real estate company CR Capital Real Estate AG.

93M1 Intrinsic Value
29.77 EUR
Undervaluation 24%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
114 602.5%
=
Net Income
29.5m
/
Revenue
25.8k
What is the Net Margin of MPH Health Care AG?

Based on MPH Health Care AG's most recent financial statements, the company has Net Margin of 114 602.5%.